Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin

In four 24-week controlled studies, the antihyperglycaemic efficacy of saxagliptin was demonstrated in patients with type 2 diabetes mellitus as add-on therapy to glyburide, a thiazolidinedione, or metformin, and when used in initial combination with metformin vs. metformin monotherapy in drug-naive...

Full description

Bibliographic Details

Published in:	International journal of clinical practice (Esher) Vol. 67; no. 8; p. 759
Main Authors:	Karyekar, C S, Frederich, R, Ravichandran, S
Format:	Journal Article
Language:	English
Published:	England 01-08-2013
Subjects:	Adamantane - analogs & derivatives Adamantane - therapeutic use Area Under Curve Controlled Clinical Trials as Topic Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Dipeptides - therapeutic use Drug Therapy, Combination Glyburide - therapeutic use Glycated Hemoglobin A - metabolism Humans Hypoglycemia - prevention & control Hypoglycemic Agents - therapeutic use Metformin - therapeutic use Treatment Outcome
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!